digital currency mining app, searches

Behind the cheers of the shooting of American medical insurance executives: blood-sucking insurance companies and the new threat of "ghost guns", the suspect who shot and killed a senior executive of an American medical insurance company in the streets of new york City was arrested on the 9th. Police said on the 11th that a number of evidences have confirmed the criminal facts of suspect Luigi Man Ghione. After the shooting, the American public's anger against medical insurance companies broke out on the Internet, and the "ghost gun" 3D printed pistol used by the suspect also showed that the problem of gun proliferation in the United States became increasingly difficult to solve. Agence France-Presse reported that since Thompson was shot, the voice of ridicule and satire has flooded the Internet, and the lack of sympathy has become the mainstream sentiment of the public, which reflects the dissatisfaction and anger of Americans towards the medical system. (CCTV)Iflytek and other robot technology companies have a registered capital of 30 million yuan. According to Tianyancha App, Anhui Lingdong General Robot Technology Co., Ltd. was recently established with Hu Guoping as the legal representative and a registered capital of 30 million yuan. Its business scope includes industrial robot manufacturing, industrial robot sales, intelligent robot research and development, electrical equipment sales, computer software and hardware and auxiliary equipment retail, information system integration services, intelligent robot sales, mechanical equipment leasing, etc. According to shareholder information, the company is jointly held by Anhui Xunfei Yunchuang Technology Co., Ltd., a subsidiary of Iflytek (002230), Anhui Yanzhi Technology Co., Ltd. and Anhui Lingji Wanwu Technology Partnership (Limited Partnership).Extremely Yue insiders: Xia Yiping still stays in the company's on-site office and is seeking financing. I learned from the inside of Extremely Yue Automobile that on the morning of December 12, Extreme Yue CEO Xia Yiping appeared in the company's headquarters office. Xia Yiping said that he appeared first to prove to employees that he had not run away, to tide over the difficulties with the company, and second to communicate with employees face to face. "His main task at present is financing, and he is also actively contacting investors for help." Insiders revealed to reporters. (The Paper)

A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)SAIC: Haitong Taicang Automobile Terminal has been put into production and operation. According to the official WeChat official account news of SAIC, today, Haitong Taicang Automobile Terminal jointly built by SAIC, Shanghai Port Group and Jiangsu Port Group has been put into production and operation, with an annual throughput of 1.3 million vehicles.Sources: The Bank of Japan tends to keep interest rates unchanged next week. Five sources familiar with the Bank of Japan's thinking said that the Bank of Japan tends to keep interest rates unchanged next week because policymakers tend to spend more time examining overseas risks and clues about salary increase next year. Any similar decision will increase the possibility that the Bank of Japan will raise interest rates at its meeting in January or March next year, when there will be more information about the wage increase next year. The source also said that there was no consensus within the Bank of Japan on the final decision, and some people in the Committee still believed that Japan had met the conditions for raising interest rates in December. This decision will depend on each member's belief in the possibility of achieving wage-driven sustained price increases in Japan. If upcoming events, such as next week's meeting of the Federal Reserve, trigger another sharp fall in the yen, thus intensifying inflationary pressure, the Bank of Japan may also agree to raise interest rates. But overall, many BoJ policymakers seem to be in no hurry to pull the trigger.

Citigroup: Pinduoduo, which operates retail platform Temu, is likely to continue to face short-term disadvantages. Maintain the neutral rating of ADR in Pinduoduo and set the target price of ADR in Pinduoduo at $125.00. Note: The latest ADR report in Pinduoduo is $103.42.Nanchang land port "Changsha-Xiamen-Hong Kong Link" rail-sea intermodal train was opened. On the morning of December 12th, two trains loaded with "Made in Jiangxi" drove out of Nanchang land port in turn under the supervision of Ganjiang New District Customs, marking the official opening of the "Changsha-Xiamen-Hong Kong Link" rail-sea intermodal train from Nanchang land port to Xiamen Port, which greatly boosted the construction of modern logistics system in Jiangxi to a new level.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)